These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 25963338)

  • 1. Bactericidal efficacy of atmospheric pressure non-thermal plasma (APNTP) against the ESKAPE pathogens.
    Flynn PB; Higginbotham S; Alshraiedeh NH; Gorman SP; Graham WG; Gilmore BF
    Int J Antimicrob Agents; 2015 Jul; 46(1):101-7. PubMed ID: 25963338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Salivary Protein Histatin 5 Has Potent Bactericidal Activity against ESKAPE Pathogens.
    Du H; Puri S; McCall A; Norris HL; Russo T; Edgerton M
    Front Cell Infect Microbiol; 2017; 7():41. PubMed ID: 28261570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cold atmospheric pressure plasma elimination of clinically important single- and mixed-species biofilms.
    Modic M; McLeod NP; Sutton JM; Walsh JL
    Int J Antimicrob Agents; 2017 Mar; 49(3):375-378. PubMed ID: 28161488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential cellular targets and antibacterial efficacy of atmospheric pressure non-thermal plasma.
    Alkawareek MY; Gorman SP; Graham WG; Gilmore BF
    Int J Antimicrob Agents; 2014 Feb; 43(2):154-60. PubMed ID: 24139886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kisameet Clay Exhibits Potent Antibacterial Activity against the ESKAPE Pathogens.
    Behroozian S; Svensson SL; Davies J
    mBio; 2016 Jan; 7(1):e01842-15. PubMed ID: 26814180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of atmospheric pressure nonthermal plasma for the in vitro eradication of bacterial biofilms.
    Alkawareek MY; Algwari QT; Gorman SP; Graham WG; O'Connell D; Gilmore BF
    FEMS Immunol Med Microbiol; 2012 Jul; 65(2):381-4. PubMed ID: 22329678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norfloxacin salts of carboxylic acids curtail planktonic and biofilm mode of growth in ESKAPE pathogens.
    Lowrence RC; Ramakrishnan A; Sundaramoorthy NS; Shyam A; Mohan V; Subbarao HMV; Ulaganathan V; Raman T; Solomon A; Nagarajan S
    J Appl Microbiol; 2018 Feb; 124(2):408-422. PubMed ID: 29178633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding the potential of NAI-107 for treating serious ESKAPE pathogens: synergistic combinations against Gram-negatives and bactericidal activity against non-dividing cells.
    Brunati C; Thomsen TT; Gaspari E; Maffioli S; Sosio M; Jabes D; Løbner-Olesen A; Donadio S
    J Antimicrob Chemother; 2018 Feb; 73(2):414-424. PubMed ID: 29092042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bactericidal effects of non-thermal argon plasma in vitro, in biofilms and in the animal model of infected wounds.
    Ermolaeva SA; Varfolomeev AF; Chernukha MY; Yurov DS; Vasiliev MM; Kaminskaya AA; Moisenovich MM; Romanova JM; Murashev AN; Selezneva II; Shimizu T; Sysolyatina EV; Shaginyan IA; Petrov OF; Mayevsky EI; Fortov VE; Morfill GE; Naroditsky BS; Gintsburg AL
    J Med Microbiol; 2011 Jan; 60(Pt 1):75-83. PubMed ID: 20829396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-year surveillance of ESKAPE pathogens in an intensive care unit of Monterrey, Mexico.
    Llaca-Díaz JM; Mendoza-Olazarán S; Camacho-Ortiz A; Flores S; Garza-González E
    Chemotherapy; 2012; 58(6):475-81. PubMed ID: 23548324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the bactericidal effect of cold atmospheric pressure plasma (CAPP), antimicrobial photodynamic therapy (aPDT), and polihexanide (PHX) in a novel wet surface model to mimic oral cavity application.
    Hafner S; Ehrenfeld M; Neumann AC; Wieser A
    J Craniomaxillofac Surg; 2018 Dec; 46(12):2197-2202. PubMed ID: 30316654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress and challenges in implementing the research on ESKAPE pathogens.
    Rice LB
    Infect Control Hosp Epidemiol; 2010 Nov; 31 Suppl 1():S7-10. PubMed ID: 20929376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of the ESKAPE pathogens.
    Pendleton JN; Gorman SP; Gilmore BF
    Expert Rev Anti Infect Ther; 2013 Mar; 11(3):297-308. PubMed ID: 23458769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential anti-microbial secondary metabolites in different ESKAPE pathogens explain their adaptation in the hospital setup.
    Tiwari V; Meena K; Tiwari M
    Infect Genet Evol; 2018 Dec; 66():57-65. PubMed ID: 30227225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eradication of Pseudomonas aeruginosa biofilms by atmospheric pressure non-thermal plasma.
    Alkawareek MY; Algwari QT; Laverty G; Gorman SP; Graham WG; O'Connell D; Gilmore BF
    PLoS One; 2012; 7(8):e44289. PubMed ID: 22952948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenylate kinase release as a high-throughput-screening-compatible reporter of bacterial lysis for identification of antibacterial agents.
    Jacobs AC; Didone L; Jobson J; Sofia MK; Krysan D; Dunman PM
    Antimicrob Agents Chemother; 2013 Jan; 57(1):26-36. PubMed ID: 23027196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-aqueous glycerol monolaurate gel exhibits antibacterial and anti-biofilm activity against Gram-positive and Gram-negative pathogens.
    Mueller EA; Schlievert PM
    PLoS One; 2015; 10(3):e0120280. PubMed ID: 25799455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of multi-drug-resistant pathogens with non-thermal-plasma-treated alginate wound dressing.
    Poor AE; Ercan UK; Yost A; Brooks AD; Joshi SG
    Surg Infect (Larchmt); 2014 Jun; 15(3):233-43. PubMed ID: 24749699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyhexamethylene guanidine hydrochloride shows bactericidal advantages over chlorhexidine digluconate against ESKAPE bacteria.
    Zhou Z; Wei D; Lu Y
    Biotechnol Appl Biochem; 2015; 62(2):268-74. PubMed ID: 24888899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ESKAPEing the labyrinth of antibacterial discovery.
    Tommasi R; Brown DG; Walkup GK; Manchester JI; Miller AA
    Nat Rev Drug Discov; 2015 Aug; 14(8):529-42. PubMed ID: 26139286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.